Clinical Trial Update: Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety and efficacy of Lumason/SonoVue in patients undergoing pharmacologic stress for coronary artery disease has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• LUMASON (sulfur hexafluoride lipid microspheres)
• SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-08-05